Danish firm Lundbeck has decided to discontinue supplies of its leukaemia drug Elspar from December after struggling to find a …
Boyds expands Regulatory Affairs team to support growing demand
Sterling doubles ADC manufacturing capacity at Welsh facility
Femtosecond laser cuts lung tumour margin assessment time
Blood sensor detects Parkinson’s-associated proteins in 40 minutes

